flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution
flurbiprofen sodium
RxCUI: 1243585
What the CMS Formulary Data Shows for flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution
Per the CMS 2026 Part D formulary file, flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution (RxNorm concept RXCUI 1243585, generic name flurbiprofen sodium) appears on 326 distinct formulary files spanning 4,954 Medicare Part D plan offerings - 97.8% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.1.
Real-world access to flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 8,299 Part D beneficiaries filled flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution in 2023, with total plan-and-beneficiary spending of $681,212 and an average per-beneficiary annual cost of $82.08. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution today.
Coverage Details
- Formularies covering
- 326
- Plans covering
- 4,954
- Coverage rate
- 97.8%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 8,299
- Total spending
- $681,212
- Avg per beneficiary
- $82.08
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Anthem Full Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Kidney Care (HMO-POS C-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Full Dual Advantage Select (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
Medicare Advantage Plans (MA-PD) Covering flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution
95 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution covered by Medicare Part D?
Yes, flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution is covered by 4,954 Medicare Part D plans (97.8% of all Part D formularies).
What tier is flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution on Medicare Part D plans?
flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution averages Tier 2.1 across Part D plans, ranging from Tier 1 to Tier 4.
Does flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution require prior authorization?
0% of Part D formularies require prior authorization for flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution. Step therapy: 0%. Quantity limits: 0.6%.
How much does Medicare spend on flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution?
In 2023, total Medicare Part D spending on flurbiprofen sodium 0.3 MG/ML Ophthalmic Solution was $681,212, covering 8,299 beneficiaries. The average spend per beneficiary was $82.08.
Read our methodology - how this data is sourced, computed, and verified.